Matches in Wikidata for { <http://www.wikidata.org/entity/Q38100606> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q38100606 description "article científic" @default.
- Q38100606 description "article scientifique" @default.
- Q38100606 description "articol științific" @default.
- Q38100606 description "articolo scientifico" @default.
- Q38100606 description "artigo científico" @default.
- Q38100606 description "artigo científico" @default.
- Q38100606 description "artigo científico" @default.
- Q38100606 description "artikel ilmiah" @default.
- Q38100606 description "artikull shkencor" @default.
- Q38100606 description "artículo científico" @default.
- Q38100606 description "artículu científicu espublizáu en 2013" @default.
- Q38100606 description "bilimsel makale" @default.
- Q38100606 description "scienca artikolo" @default.
- Q38100606 description "scientific article published on 20 April 2013" @default.
- Q38100606 description "scientific article published on 20 April 2013" @default.
- Q38100606 description "scientific article published on 20 April 2013" @default.
- Q38100606 description "vedecký článok" @default.
- Q38100606 description "vetenskaplig artikel" @default.
- Q38100606 description "videnskabelig artikel" @default.
- Q38100606 description "vitenskapelig artikkel" @default.
- Q38100606 description "vitskapeleg artikkel" @default.
- Q38100606 description "vědecký článek" @default.
- Q38100606 description "wetenschappelijk artikel" @default.
- Q38100606 description "wissenschaftlicher Artikel" @default.
- Q38100606 description "наукова стаття, опублікована у квітні 2013" @default.
- Q38100606 description "научная статья" @default.
- Q38100606 description "научни чланак" @default.
- Q38100606 description "מאמר מדעי" @default.
- Q38100606 description "مقالة علمية نشرت في 20 أبريل 2013" @default.
- Q38100606 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38100606 name "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 name "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 name "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 type Item @default.
- Q38100606 label "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 label "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 label "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 prefLabel "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 prefLabel "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 prefLabel "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 P1433 Q38100606-7362609D-EDFD-4A47-BA56-AAF95760C11C @default.
- Q38100606 P1476 Q38100606-BEC49AB8-FC26-4842-BA3E-436BBA834D04 @default.
- Q38100606 P2093 Q38100606-62E69626-FC09-4C42-BBB8-3CD0BC86E2A3 @default.
- Q38100606 P304 Q38100606-9E6FBE82-29FD-4EE3-BEBF-95088367ED28 @default.
- Q38100606 P31 Q38100606-08BDC61A-0455-4337-AC93-E03581942325 @default.
- Q38100606 P356 Q38100606-DBBDCF61-1BE1-42D3-9E4F-33AC2C65E2B1 @default.
- Q38100606 P407 Q38100606-38121D49-187B-42F0-BA09-68BE4AA06959 @default.
- Q38100606 P433 Q38100606-9767300F-8518-4F62-8325-81A5C7D58A7F @default.
- Q38100606 P478 Q38100606-816671E9-0A11-4673-A753-ACD316903607 @default.
- Q38100606 P577 Q38100606-C2164A35-F550-4CA7-B462-CFEBD01D381D @default.
- Q38100606 P698 Q38100606-449A012C-35C2-4DE6-AB9A-01202AE3A70E @default.
- Q38100606 P921 Q38100606-56903EEF-C475-443A-B2A0-02CD63DB40A2 @default.
- Q38100606 P921 Q38100606-979875D3-81CA-4B32-BC89-D8C303DB5BE3 @default.
- Q38100606 P356 EB-2013-101304 @default.
- Q38100606 P698 23604277 @default.
- Q38100606 P1433 Q5418311 @default.
- Q38100606 P1476 "Review: In alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving" @default.
- Q38100606 P2093 "Michael Soyka" @default.
- Q38100606 P304 "71" @default.
- Q38100606 P31 Q13442814 @default.
- Q38100606 P356 "10.1136/EB-2013-101304" @default.
- Q38100606 P407 Q1860 @default.
- Q38100606 P433 "3" @default.
- Q38100606 P478 "16" @default.
- Q38100606 P577 "2013-04-20T00:00:00Z" @default.
- Q38100606 P698 "23604277" @default.
- Q38100606 P921 Q2647488 @default.
- Q38100606 P921 Q409587 @default.